Zobrazeno 1 - 10
of 10
pro vyhledávání: '"L M Albrecht"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:1547-1550
The efficacy of fleroxacin was compared with that of vancomycin by using the rabbit model of methicillin-susceptible Staphylococcus aureus endocarditis. Animals received intravenous therapy with fleroxacin, 30 mg/kg every 8 h, or vancomycin, 17.5 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0589f4347f904bcc6acde86a5c8ebe81
https://doi.org/10.1128/aac.35.8.1547
https://doi.org/10.1128/aac.35.8.1547
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:792-795
The pharmacokinetics of vancomycin were evaluated in 34 patients (10 burn patients, 14 intravenous drug abusers [IVDA], and 10 controls). Multiple serum samples were drawn following a 1-h vancomycin infusion at steady state over an 8- to 12-h dosing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2178ba505451a7c59d9dccb94d328e9
https://doi.org/10.1128/aac.34.5.792
https://doi.org/10.1128/aac.34.5.792
Autor:
L M Albrecht, Donald P. Levine, P L McNeil, Stephen A. Lerner, M T Kenny, Michael J. Rybak, L Yuh, G A Thompson
Publikováno v:
Antimicrobial agents and chemotherapy. 35(4)
The pharmacokinetics of teicoplanin were determined after multiple 30-min intravenous infusions of 10 to 15 mg/kg every 12 to 24 h in 11 intravenous drug abuse (IVDA) patients being treated for bacterial endocarditis. Multiple serum samples were obta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b035f525340a822dac1baee6b66d71f
https://pubmed.ncbi.nlm.nih.gov/1829880
https://pubmed.ncbi.nlm.nih.gov/1829880
Publikováno v:
Antimicrobial agents and chemotherapy. 34(2)
The efficacy of ofloxacin was compared with that of vancomycin in the therapy of experimental Staphylococcus aureus endocarditis. Rabbits infected with either a methicillin-susceptible (MSSA-1199) or a methicillin-resistant (MRSA-494) test strain wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ce11b8a5fab0607e195a40c0d3c235f
https://pubmed.ncbi.nlm.nih.gov/2327773
https://pubmed.ncbi.nlm.nih.gov/2327773
Publikováno v:
Antimicrobial Agents and Chemotherapy. 31:1461-1464
The effects of vancomycin, gentamicin, and combination vancomycin-gentamicin treatments on alanine aminopeptidase (AAP) and beta 2-microglobulin (beta 2M) elimination in 30 hospitalized patients were assessed and compared with elimination in a contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79661e95b0fdfc6b213873ee3167a49
https://doi.org/10.1128/aac.31.10.1461
https://doi.org/10.1128/aac.31.10.1461
Publikováno v:
Antimicrobial Agents and Chemotherapy. 33:519-521
The efficacy of fleroxacin versus that of vancomycin was assessed by using the rabbit model of methicillin-resistant Staphylococcus aureus endocarditis. Animals were treated with fleroxacin (30 mg/kg of body weight every 8 h) or vancomycin (17.5 mg/k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::062a7ef1d2ebd5538083b75305bb6097
https://doi.org/10.1128/aac.33.4.519
https://doi.org/10.1128/aac.33.4.519
Publikováno v:
Antimicrobial agents and chemotherapy. 33(8)
The therapeutic activities of ciprofloxacin (25 mg/kg every 8 h), rifampin (10 mg/kg every 24 h), ciprofloxacin plus rifampin, and vancomycin (17.5 mg/kg every 6 h) were compared by using the rabbit model of Staphylococcus aureus endocarditis. Animal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e264e49d25fd1106aacc75c5b2fb33c7
https://pubmed.ncbi.nlm.nih.gov/2802547
https://pubmed.ncbi.nlm.nih.gov/2802547
Publikováno v:
Therapeutic drug monitoring. 10(1)
The predictive ability of a four-point sampling method versus a two-point sampling method for vancomycin was assessed in 11 patients with various staphylococcal infections. All steady-state predictions were based on first-dose pharmacokinetic paramet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::203aed6521b39da014b1d40120a0d0ee
https://pubmed.ncbi.nlm.nih.gov/3376187
https://pubmed.ncbi.nlm.nih.gov/3376187
Publikováno v:
Sexually transmitted diseases. 16(2)
Enoxacin, a new broad spectrum azaquinolone, has demonstrated in-vitro activity against Neisseria gonorrhoeae including penicillinase producing strains. We evaluated the safety and efficacy or oral enoxacin 400 mg versus intramuscular ceftriaxone 250
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc53492c0d7b085e2f521849d88e59dc
https://pubmed.ncbi.nlm.nih.gov/2500718
https://pubmed.ncbi.nlm.nih.gov/2500718
Autor:
L M Albrecht, Michael J. Rybak
Publikováno v:
Drug Intelligence & Clinical Pharmacy. 20:506-506
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d7685cf8e95b3f6554c404438bb95e
https://doi.org/10.1177/106002808602000618
https://doi.org/10.1177/106002808602000618